ZNF169 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 9.19639919771953E-11 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.725599999995E-05 |
Normal-vs-Stage2 |
4.182200E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
5.255800E-03 |
Stage1-vs-Stage2 |
2.777000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.488200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
8.298800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.37140001763714E-09 |
Normal-vs-AfricanAmerican |
1.06280000022885E-07 |
Normal-vs-Asian |
1.31489999999346E-07 |
Caucasian-vs-AfricanAmerican |
7.077000E-01 |
Caucasian-vs-Asian |
8.279200E-01 |
AfricanAmerican-vs-Asian |
1.205400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.15839999999834E-05 |
Normal-vs-Female |
1.26499999997254E-06 |
Male-vs-Female |
8.808600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.658400E-03 |
Normal-vs-Extreme_Weight |
2.27369999999949E-05 |
Normal-vs-Obese |
2.264900E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
2.350000E-01 |
Normal_Weight-vs-Obese |
2.283800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.776400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.40550004967821E-09 |
Normal-vs-Age(41-60Yrs) |
2.954100E-04 |
Normal-vs-Age(61-80Yrs) |
4.26509999995606E-06 |
Normal-vs-Age(81-100Yrs) |
1.923630E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.781750E-04 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.496380E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.305600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.983200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.219400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.297600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.311030E-01 |
Normal-vs-Grade 3 |
5.745800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
1.041780E-01 |
Grade 2-vs-Grade 4 |
1.311030E-01 |
Grade 3-vs-Grade 4 |
5.745800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.3079000005245E-07 |
Normal-vs-N1 |
3.978500E-03 |
N0-vs-N1 |
9.222500E-02 |
|
|